Recent News

• 03.25.2026 - ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights
• 03.19.2026 - BriefGlance.com: ProMIS Unveils Precision Vaccines for ALS and Parkinson's Disease
• 03.18.2026 - ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)

Recent Filings

• 03.18.2026 - S-3 Registration statement under Securities Act of 1933
• 03.18.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2026 - 3 Initial statement of beneficial ownership of securities
• 02.23.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.10.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.06.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors